HONG KONG, CHINA - MediaOutReach - 5 November 2019 - Jacobson Pharma Corporation Limited ("JacobsonPharma" or the  "Company"; Stock Code:2633), a leading company engaged in research,development, production, marketing and sale of generic drugs and proprietarymedicines, announced today that its wholly-owned subsidiary Jacobson Medical (Hong Kong) Limited ("Jacobson")has signed an exclusive distribution agreement  (the "Agreement") with Vemedia ShineLimited ("Vemedia") (a wholly-owned subsidiary of VersaillesB.V., a companyincorporated in the Netherlands) for the marketing and distributionof  "Excilor" (「恢甲清」)range ofproducts  in the market of MainlandChina.

Photo for product(s) of Excilor being currently sold in Hong Kong. Excilor (「恢甲清」) is a leading over-the-counter brand in Hong Kong for nail and foot care. 

Jacobsonwill be the exclusive distributor for Vemedia for the marketing, sales anddistribution of Vemedia's highly recognised medicated nail and footcare brand, namely "Excilor"「恢甲清」, in the China market fora term of tenyears.

Mr. Derek Sum,Chairman and Chief Executive Officer ofJacobson Pharma remarked, "The strategiccollaboration represents a sound leverage of strengths and resources betweenJacobson and Vemedia. By riding on its established market network, JacobsonPharma aims to build a strong position for the Excilor brand whilst tapping the fast-growing nail and foot care market in China.  Itis one of our strategic goals to maximize the value and market potential of theExcilor brand and create synergies with Vemedia via a sustainable collaboration."

The appointment ofJacobson as the exclusive distributor of Excilor in the Mainland China willenhance the product portfolio of Jacobson Pharma and further strengthen itsmarket position in capitalizing on the rising consumer demand for branded healthcareproducts in the burgeoning market of China.

Jacobson Pharma hasbeen forging strategic collaborations with variousbusiness partners. A case in point is the recently-formed joint venture alliance with Weisen-U (「胃仙-U」) and FlucurNebuliser (「呼佳噴霧劑」). The Group currentlypossesses a portfolio of proprietary healthcare brands such as Po Chai Pills (「保濟丸」), Ho Chai Kung TjiThung San (「何濟公止痛退熱散」), Contractubex ScarGel (「秀碧除疤膏」), Flying Eagle WoodLok Medicated Oil (「飛鷹活絡油」), Tong Tai ChungWoodlok Oil (「唐太宗活絡油」), Doan's Ointment (「兜安氏藥膏」), Saplingtan (「十靈丹」), Shiling Oil (「十靈油」), and Col-ganTablet (「傷風克」).  

About Jacobson Pharma Corporation Limited (雅各臣科研製藥有限公司；Stock Code: 2633)

Jacobson Pharma is a leading generic drug company in Hong Kong. The Group'sproprietary medicines, notably being Po Chai Pills (「保濟丸」), Ho Chai Kung Tji Thung San (「何濟公止痛退熱散」), Contractubex Scar Gel (「秀碧除疤膏」) , Flying Eagle Wood Lok Medicated Oil (「飛鷹活絡油」), Tong Tai Chung Woodlok Oil (「唐太宗活絡油」), Doan's Ointment (「兜安氏藥膏」), Saplingtan (「十靈丹」), Shiling Oil (「十靈油」) and Col-gan Tablet (「傷風克」) have been widely recognised by the market.The Group aims to enrich its portfolio through addition of high value-added productscovering sterile injections, oncology products as well as orphan drugs andbiosimilars. With its corporateheadquarters based in Hong Kong, the Group has also established its operatingsubsidiaries in China, Macau, Taiwan, Singapore and Cambodia forminga regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharmahas been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June2017. For more details about Jacobson Pharma, please visit the Group's website:https://www.jacobsonpharma.com

About Vemedia Shine Limited

Vemedia is a fast growing reputable consumer healthcare companyheadquartered in Diemen, the Netherlands, marketing a portfolio of leadingself-medicated brands in certain European countries. Excilor, a well-recognizedbrand under Vemedia, primes itself as the specialist in medical foot care andenjoys a preeminent position in the over-the-counter (OTC) market for thetreatment of fungal nail infection.